Arif Nurkanto

Arif Nurkanto

Auto-generated profile, based on publicly available information

Arif Nurkanto

National Research and Innovation Agency, Indonesia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2022 in Drug Delivery
Verified
Journal Article
Open access
AMAndang Miatmoko
Andang Miatmoko
NMNurul Ailda Marufah
Nurul Ailda Marufah
QNQothrin Nada
Qothrin Nada
NRNoorma Rosita
Noorma Rosita
TETristiana Erawati
Tristiana Erawati
WSWidji Soeratri
Widji Soeratri
1. Skin aging, a complex progressive biological process caused by both intrinsic and extrinsic factors, negatively affects its appearance (Sjerobabski-Masnec & Šitum, 2010). The extrinsic impact of...

1 January 2009 in The Journal of General and Applied Microbiology
Verified
Journal Article
Open access
PDF file
KIKazuo Isobe
Kazuo Isobe
HSHirotaka Sumi
Hirotaka Sumi
ISImade Sudiana
Imade Sudiana
ANArif Nurkanto
Arif Nurkanto
KSKeishi Senoo
Keishi Senoo
Soil bacterial community compositions in burnt and unburnt areas in a tropical rainforest in East Kalimantan, Indonesia, were investigated 8 and 9 years after a fire by denaturing gradient gel electrophoresis analysis targeting the 16S rRNA gene. Three study sites were set in the forest area devoid of fire damage (control), and in the lightly damaged and heavily damaged forest areas. Succession of aboveground vegetation in the two damaged areas had clearly proceeded after the fire, but the vegetation types still differed from the unburnt area at the time of this study. Community composition of total soil bacteria was similar among the three areas, and so was that of actinobacteria. However, the composition of ammonia oxidizing bacteria clearly differed depending on the presence or absence of past fire damage. These results indicate that even nearly a decade after the forest fire, impacts of the fire remained on the community composition of ammonia oxidizing bacteria, but not apparently on those of dominant bacteria and actinobacteria.

15 November 2022 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
ANArif Nurkanto
Arif Nurkanto
RIRiyo Imamura
Riyo Imamura
YRYulia Rahmawati
Yulia Rahmawati
EPErwahyuni Endang Prabandari
Erwahyuni Endang Prabandari
DWDanang Waluyo
Danang Waluyo
TNTomoyoshi Nozaki
Tomoyoshi Nozaki
Malaria is a mosquito-borne fatal infectious disease that affects humans and is caused by Plasmodium parasites, primarily Plasmodium falciparum . Widespread drug resistance compels us to discover novel compounds and alternative drug discovery targets.

4 August 2024 in Heliyon
Verified
Journal Article
Open access
ANArif Nurkanto
Arif Nurkanto
MAMasrukhin
Masrukhin
JTJoseph Calvin Erdian Tampubolon
Joseph Calvin Erdian Tampubolon
MEMuhammad Farrel Ewaldo
Muhammad Farrel Ewaldo
APAde Lia Putri
Ade Lia Putri
TNTomoyoshi Nozaki
Tomoyoshi Nozaki
Tuberculosis (TB) is the foremost cause of infectious fatality globally. The primary global challenge in combatting TB lies in addressing the emergence of drug-resistant variants of the disease. However, the number of newly approved agents for treating TB has remained remarkably low over recent decades. Hence, research endeavors for discovering novel anti-TB agents are always needed. In the present study, we screened over 1,500 culture extracts from actinomycetes isolated in Indonesia for their inhibitory activity against Mycobacterium smegmatis used as a surrogate in the primary screening. The initial screening yielded approximately 6.2 % hit extracts, with a selection criterion of >80 % growth inhibition. The confirmed hit extracts were subsequently subjected to growth inhibition assay against Mycobacterium bovis and Mycobacterium tuberculosis. Approximately 20 % of the hit extracts that showed growth inhibition also exhibited efficacy against M. bovis BCG and M. tuberculosis H37Rv pathogenic strain. An active compound was successfully purified from a large-scale culture of the most potent representative extract by high-performance liquid chromatography and thin-layer chromatography. The structure of the active compound was elucidated by mass spectrometry and nuclear magnetic resonance. This compound displayed structural similarities to actinomycin group and exhibited robust inhibition, with IC50 values of 0.74, 0.02, and 0.07 μg/mL against M. smegmatis, M. bovis, and M. tuberculosis, respectively. The Actinomycetes strain A612, which produced the active compound, was taxonomically classified by phylogenetic analysis of 16s rRNA gene and whole genome sequencing data as Streptomyces parvus. Computational genome analysis utilizing anti-SMASH 7.0 unveiled that S. parvus A612 strain harbors 40 biosynthetic gene clusters with the potential to produce 16 known (with >70 % similarity) and 24 unknown compounds. A non-ribosomal peptide synthesis (NRPS) gene cluster associated with actinomycin D biosynthesis was also identified, boasting an 85 % similarity. Molecular docking analysis of actinomycin D and 21 potential M. tuberculosis targets revealed possible interactions with multiple targets. The purified active compound inhibited recombinant M. tuberculosis shikimate kinase (MtSK), which validated the results obtained from the docking analysis.

1 January 2025 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
BHB.S. Hariawan
B.S. Hariawan
AMAndang Miatmoko
Andang Miatmoko
QAQonita Kurnia Anjani
Qonita Kurnia Anjani
FAF. Annuryanti
F. Annuryanti
DKD.B. Kamadjaja
D.B. Kamadjaja
DHDewi Hariyadi
Dewi Hariyadi
Bone fractures must undergo a complex healing process involving intricate cellular and molecular mechanisms. They require a suitable biological environment to restore skeletal stability and resolve inflammation. Scaffolds play a vital role in bone regeneration, thus reducing disease burden. Autologous bone graft represents the gold standard of therapy. However, its application is limited due to various reasons. Nanotechnology, in the form of nanomaterials and nano-drug delivery systems, has been proven to increase the potency of active substances in mimicking extracellular matrix (ECM), thereby providing physical support benefits and enhancing therapeutic effectiveness. Various materials, including protein, metal oxide, hydroxyapatite, and silica are modified with nanoparticle technology for the purposes of tissue regeneration therapy. Moreover, the properties of nanomaterials such as size, seta potential, and surface properties will affect their effectiveness in bone regeneration therapy. This review provides insights that deepen the knowledge of the manufacturing and application of nanomaterials as a therapeutic agent for bone regeneration.

28 September 2024 in European Polymer Journal
Verified
Journal Article
Closed access
BHBerlian Sarasitha Hariawan
Berlian Sarasitha Hariawan
DCDevy Maulidya Cahyani
Devy Maulidya Cahyani
QAQonita Kurnia Anjani
Qonita Kurnia Anjani
FAFebri Annuryanti
Febri Annuryanti
DKDavid Buntoro Kamadjaja
David Buntoro Kamadjaja
AMAndang Miatmoko
Andang Miatmoko